cagrisema vs semaglutide Three new phase 3 REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type 2 diabetes. 🔹 REIMAGINE 1 Studied people with early type 2 diabetes Novo Nordisk launches trial of

There was no change in fasting plasma glucose for either group, the researchers reported

Get Started with Our Free Weight Loss Ebook As part of our commitment to your health journey, we offer a free weight loss ebook designed to empower you with the knowledge and tools to maximize your results

Novo Nordisk's large late-stage trial testing semaglutide as an Alzheimer's treatment failed to show significant cognitive improvement in patients, Reuters reported

We review your history, rule out other drivers, and often order stool analysis, food-sensitivity panels, and inflammatory markers before recommending the protocol